Evidence map›Paper›PMID 35351263›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2022

Detection of

Yan-Ling Yao, Xi-Ge Wang, Xue-Lian Zhao, Shuai-Quan Li, Yu-Jie Zhou, Yi-Zhuo Xu

Open access · greenAbstract read
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yan-Ling YaoDepartment of Hematology, Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Xi-Ge WangDepartment of Hematology, Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Xue-Lian ZhaoDepartment of Hematology, Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Shuai-Quan LiDepartment of Hematology, Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Yu-Jie ZhouDepartment of Hematology, Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Yi-Zhuo XuDepartment of Hematology, Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Third Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the mutation rate of the

methodsA retrospective analysis was performed on the medical data of 120 children with newly diagnosed acute lymphoblastic leukemia, who were admitted to the Third Affiliated Hospital of Zhengzhou University from January 2015 to January 2020 and underwent next-generation sequencing. The clinical and molecular features were analyzed. The impact of

resultsAmong the 120 children, 35 (29.2%) had

conclusions

Indexed as

Genes, rasPrecursor Cell Lymphoblastic Leukemia-LymphomaChildHumansMutationPrognosisRetrospective StudiesAcute lymphoblastic leukemiaChildMutationPrognosisRAS gene

Identifiers

PMID35351263
PMCPMC8974658
OpenAlexW4220825851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.